AbelZeta to Attend 43rd Annual J.P. Morgan Healthcare Conference and Join Panel at 8th Annual BFC Healthcare Conference
ROCKVILLE, Md., Dec. 23, 2024 /PRNewswire/ -- AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based


